True Leaf Is Assigned LEI Number

DGAP-News: True Leaf Medicine International Ltd. / Key word(s): Miscellaneous

29.12.2017 / 13:10

The issuer is solely responsible for the content of this announcement.

True Leaf Is Assigned LEI Number

VERNON, BC, CANADA (December 29, 2017) – True Leaf Medicine International Ltd. (“True Leaf” or the “Company“) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), announces that it has been assigned the Legal Entity Identifier (“LEI”) number 5299001MM2N2GXFEJP91. The European Union has adopted regulations that require use of the LEI as a barcode equivalent aimed at pinpointing systemic risks.

True Leaf’s acquisition of the LEI number provides the Company with a standard operating control that is required for foreign companies listed in Europe to continue trading. True Leaf meets the requirement for all companies listed on German stock exchanges (i.e. Frankfurt Stock Exchange) to have an LEI number by January 3, 2018.

About the Legal Entity Identifier (LEI)

The Legal Entity Identifier (LEI) number is a 20-digit alphanumeric code. It is an internationally standardized and globally valid identifier for financial market participants. Its purpose is to clearly and unequivocally identify contracting parties (e.g., companies, banks, and investment funds). It is used to comply with a variety of financial reporting requirements. The Deutsche Borse Group has stated that “the LEI will clearly assist the regulatory authorities in monitoring and analysing threats to the stability of the financial markets, (but) it can also be utilised by counterparties internally for risk management purposes.”

According to the website of the Deutsche Bӧrse Group, the LEI number will affect most aspects of the securities markets in Europe, including trading, clearing, settlement, custody, collateral and liquidity management, market data and indices.


About True Leaf

Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. The Company’s goal is to provide federally-approved, safe and effective cannabis products that will be sold across Canada and the United States. True Leaf Medicine Inc. was launched in July 2013 to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been given approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion to allow for the cultivation, manufacture, and distribution of cannabis products. Currently, True Leaf does not have a license to produce cannabis.

Established in 2015, True Leaf Pet Inc. markets safe, hemp-focused products for the pet industry. The Company launched the True Hemp(TM) pet supplement line in Canada, the United States, and Europe, becoming one of the first hemp-based pet product lines to be marketed worldwide. True Hemp(TM) North American products are free of CBD and THC, making them the first federally legal products to be marketed in Canada and the United States.

True Leaf International Ltd.
32 – 100 Kalamalka Lake Road
Vernon, BC V1T 9G1

Media Contact:

Paul Sullivan
Director, Public Relations
O: 604-685-4742
M: 604-603-7358

Investor Contact:

Kevin Bottomley (Canada)
Director and Corporate Relations
M: 778-389-9933

Tirth Patel (US)
Edison Advisors
O: 646-653-7035

Follow True Leaf

29.12.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at

Language: English
Company: True Leaf Medicine International Ltd.
32 – 100 Kalamalka Lake Road
V1T 9 G1 Vernon (BC)
Phone: +17783899933
ISIN: CA89785C1077, CA89785C1077
Listed: Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; Canadian Venture Exchange

End of News DGAP News Service

show this